Glory Health Industry Limited

As of December 31, 2024, Glory Health Industry Limited carries a market capitalization of 453.33M, placing it among publicly traded companies globally. Its enterprise value stands at 27.23B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2024, Glory Health Industry Limited has 4.44B shares outstanding.

These figures are as of December 31, 2024.

As of December 31, 2024, Glory Health Industry Limited maintains a current ratio of 1.03, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2024.

As of the close on October 23, 2026, Glory Health Industry Limited's stock has declined approximately 36.42% over the past 52 weeks. The 50-day moving average sits at 0.10, while the 200-day moving average is 0.11.

As of December 31, 2024, Glory Health Industry Limited holds 74.98M in cash and equivalents against 24.25B in total debt, resulting in a net debt position of 24.18B. Total book value stands at 10.57B, with working capital of 1.12B providing operational flexibility.